Evidence-Based Reviews
Evidence-Based Reviews
Long-acting injectable antipsychotics during COVID-19
How to determine if your patient should continue an LAI, and how to do so safely.
Evidence-Based Reviews
COVID-19 and the risk of homicide-suicide among older adults
Identify patients who are at risk, and implement measures to protect them.
Evidence-Based Reviews
Anticonvulsants for alcohol withdrawal: A review of the evidence
Several agents may be useful for treating mild to moderate withdrawal symptoms.
Evidence-Based Reviews
The rebirth of psychedelic psychiatry
Recent research suggests psychedelic agents might help treat anxiety, depression, other disorders
Evidence-Based Reviews
Pharmacologic management of autism spectrum disorder: A review of 7 studies
Evidence suggests some agents might help treat irritability and other symptoms associated with autism spectrum disorder.
Evidence-Based Reviews
2020 Peer Reviewers
The Editors of Current Psychiatry acknowledge the help of the following clinical experts, in addition to members of our...
Evidence-Based Reviews
Caring for outpatients during COVID-19: 4 themes
Take steps to reduce isolation, uncertainty, household stress, and grief related to COVID-19.
Evidence-Based Reviews
Managing metabolic syndrome in patients with schizophrenia
Three medications can help address weight gain, glucose levels, and dyslipidemia.
Evidence-Based Reviews
The psychiatric consequences of COVID-19: 8 Studies
Initial research explores the toll on health care workers, patients, and the general public.
Evidence-Based Reviews
Using seclusion to prevent COVID-19 transmission on inpatient psychiatry units
Ethical factors guide seclusion of patients who test positive for COVID-19 or refuse testing.
Evidence-Based Reviews
Negative symptoms of schizophrenia: An update
Treatment can be challenging, but research suggests several medications may hold promise.